Invossa
Search results
Scope
Date
~
-
Pharmeceuticals
Kolon resumes Invossa phase 3 clinical trials in US
Kolon TissueGene Inc., the cell therapies unit of South Korean pharmaceutical company Kolon Life Science Inc., said on Dec. 28 it has resumed admi...
Dec 28, 2021 (Gmt+09:00)
1